Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-22-017219
Filing Date
2022-07-15
Accepted
2022-07-15 20:03:45
Documents
1
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 6916
  Complete submission text file 0001437749-22-017219.txt   8259
Mailing Address 1415 WEST LOOP NORTH HOUSTON TX 77055
Business Address
KLEMP WALTER V (Reporting) CIK: 0000938419 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37758 | Film No.: 221087938

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations